BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: De Lorenzo R, Ramirez GA, Punzo D, Lorioli L, Rovelli R, Canti V, Barera G, Rovere-Querini P. Neonatal outcomes of children born to mothers on biological agents during pregnancy: State of the art and perspectives. Pharmacol Res 2020;152:104583. [PMID: 31816434 DOI: 10.1016/j.phrs.2019.104583] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Carnovale C, Parisi F, Battini V, Zavatta A, Cheli S, Cattaneo D, Gringeri M, Mosini G, Guarnieri G, Cammarata G, Cetin I. The use of biological agents in pregnant women affected by autoimmune disorders: Why we need more research of this neglected area. Pharmacol Res 2021;171:105786. [PMID: 34314858 DOI: 10.1016/j.phrs.2021.105786] [Reference Citation Analysis]
2 Brien ME, Gaudreault V, Hughes K, Hayes DJL, Heazell AEP, Girard S. A Systematic Review of the Safety of Blocking the IL-1 System in Human Pregnancy. J Clin Med 2021;11:225. [PMID: 35011965 DOI: 10.3390/jcm11010225] [Reference Citation Analysis]
3 O'Byrne LJ, Alqatari SG, Maher GM, O'Sullivan AM, Khashan AS, Murphy GP, McCarthy FP. Fetal and maternal outcomes after maternal biologic use during conception and pregnancy: A systematic review and meta-analysis. BJOG 2022;129:1236-46. [PMID: 35014759 DOI: 10.1111/1471-0528.17093] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Canti V, Scarrone M, De Lorenzo R, Ramirez GA, Erra R, Bordoli S, Cella S, Schmit E, Rosa S, Castiglioni MT, Rovere-Querini P. Low incidence of intrauterine growth restriction in pregnant patients with systemic lupus erythematosus taking hydroxychloroquine. Immunol Med 2021;:1-7. [PMID: 33417532 DOI: 10.1080/25785826.2020.1868652] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]